Lorena Raquel Lerner

Chief Science Officer; Chief Scientific Officer · 3 filings · Latest: Aug 18, 2026

Keros Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
KROS	Lorena Raquel Lerner	Chief Scientific Officer	Aug 18, 2026	Sale	$10.29	3,568	$36.7K	27,559	Aug 20 8:10 PM
KROS	Lorena Raquel Lerner	Chief Science Officer	Feb 18, 2026	Sale	$16.35	3,873	$63.3K	31,127	Feb 20 9:15 PM